Shopping Cart
- Remove All
- Your shopping cart is currently empty
COX-2-IN-34 is a selective, orally potent COX-2 inhibitor that shows anti-inflammatory activity without gastric ulcer toxicity during experiments in mice.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $430 | In Stock | |
10 mg | $636 | In Stock | |
25 mg | $987 | In Stock | |
50 mg | $1,360 | In Stock | |
100 mg | $1,830 | In Stock | |
500 mg | $3,680 | In Stock |
Description | COX-2-IN-34 is a selective, orally potent COX-2 inhibitor that shows anti-inflammatory activity without gastric ulcer toxicity during experiments in mice. |
Targets&IC50 | COX-2:0.42 μM, COX-1:34.86 μM |
In vitro | COX-2-IN-34 (compound 8a) (100 μM, 24 h) shows no significant cytotoxicity on RAW264.7 cells.[1] It selectively inhibits COX-1 and COX-2 activities with IC50 values of 34.86 and 0.42 μM, respectively, and at 10 μM, inhibits COX-2 by 82%.[1] |
In vivo | COX-2-IN-34 (compound 8a) (50 mg/kg; orally; 3 days; rats) exhibits no gastric ulcer toxicity in a normal male rat model. COX-2-IN-34 (50 mg/kg; s.c.; rats) shows significant reduction in edema claw volume at 0, 1, 2, 3, 4, and 6 hours post-carrageenan injection compared to the control, with 42.90% and 45.95% inhibition at the 3rd and 4th hour, respectively, closely matching Celecoxib's 45.18% inhibition at 3 hours, demonstrating significant anti-inflammatory effects in carrageenan-induced plantar edema in rats.[1] |
Molecular Weight | 245.23 |
Formula | C13H11NO4 |
Cas No. | 2788578-71-0 |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (183.5 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.